# \# 20190708170105 2000 Normal Functioning and the Treatment-Enhancement Distinction Daniels

\# \# 20190708170105 2000 Normal Functioning and the Treatment-Enhancement Distinction Daniels\
\# 20190708170105 2000 Normal Functioning and the Treatment-Enhancement Distinction Daniels tags= Daniels, 2000, Normal Functioning, Treatment-Enhancement Distinction\
PdfID=\
ï¼ƒFormatted Reference\
Daniels N. (2000) Normal Functioning and the Treatment-Enhancement Distinction. Cambridge Quarterly of Healthcare Ethics 9: 309-322.

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

\# Positive versus Negative Genetic Engineering and the Permissible-Impermissible Boundary

\> \"we may have other obligations, including those that derive from considerations of justice---such as our concern to promote equality of opportunity---that may compel us to offer some interventions that count as enhancements\" \\(Daniels, 2000\\)

Permissible: if the genetic enhancement allows general wellbeing for all.

\#Normal Functioning\# \#Daniels \#Treatment-Enhancement Distinction\# \#2000\#
